Compare MNPR & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNPR | IIIN |
|---|---|---|
| Founded | 2014 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.4M | 484.9M |
| IPO Year | 2019 | 1994 |
| Metric | MNPR | IIIN |
|---|---|---|
| Price | $117.58 | $31.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $107.00 | N/A |
| AVG Volume (30 Days) | ★ 176.4K | 122.7K |
| Earning Date | 05-08-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 4.37% |
| EPS Growth | 54.99 | ★ 112.12 |
| EPS | N/A | ★ 1.12 |
| Revenue | N/A | ★ $647,706,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $6.82 |
| P/E Ratio | ★ N/A | $27.66 |
| Revenue Growth | N/A | ★ 22.39 |
| 52 Week Low | $46.89 | $24.35 |
| 52 Week High | $124.82 | $39.91 |
| Indicator | MNPR | IIIN |
|---|---|---|
| Relative Strength Index (RSI) | 57.44 | 49.91 |
| Support Level | $103.41 | $30.49 |
| Resistance Level | $124.55 | $31.04 |
| Average True Range (ATR) | 7.07 | 0.79 |
| MACD | -0.32 | -0.13 |
| Stochastic Oscillator | 68.37 | 42.39 |
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.